Yoshimatsu Hidehiko, Karakawa Ryo, Fuse Yuma, Yano Tomoyuki
Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Department of Plastic and Reconstructive Surgery, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.
J Clin Med. 2022 Jan 21;11(3):534. doi: 10.3390/jcm11030534.
The incidence of upper extremity lymphedema after breast cancer treatment is reported to be 14% after axillary lymph node dissection (ALND) and 33% after ALND and regional lymph node dissection. The present report describes a novel method in which the afferent lymphatic vessels are harvested with their lymph nodes from the Zone 4 region as a separate flap, the superficial circumflex iliac artery perforator (SCIP) flap, in the setting of autologous breast reconstruction using the deep inferior epigastric artery perforator (DIEP) flap. From September 2017 to September 2020, seven female patients with an average age of 46.9 years (range: 39 to 54 years) underwent autologous breast reconstruction using the DIEP flap and the lymphatic SCIP flap procured separately from the Zone 4 region. All patients had undergone ALND, four patients had undergone radiation therapy, and three patients had established lymphedema at the time of reconstruction. All lymphatic SCIP flaps survived completely. Lymphedema did not occur in any of the four patients to whom the lymphatic flap was transferred for a preventive purpose (average follow-up: 37.5 months). In three patients with established lymphedema at the time of reconstruction, the average rate of estimated volume decrease at the last follow-up (average: 29.0 months) was 12.6%. A lymphatic SCIP flap procured from the Zone 4 region in DIEP flap breast reconstruction can contribute to improvement or prevention of lymphedema with no additional donor site.
据报道,乳腺癌治疗后上肢淋巴水肿的发生率在腋窝淋巴结清扫术(ALND)后为14%,在ALND和区域淋巴结清扫术后为33%。本报告描述了一种新方法,即在使用腹壁下动脉穿支(DIEP)皮瓣进行自体乳房重建的情况下,将4区的输入淋巴管及其淋巴结作为一个单独的皮瓣,即旋髂浅动脉穿支(SCIP)皮瓣进行采集。2017年9月至2020年9月,7例平均年龄46.9岁(范围:39至54岁)的女性患者接受了DIEP皮瓣和从4区单独获取的淋巴SCIP皮瓣的自体乳房重建。所有患者均接受了ALND,4例患者接受了放射治疗,3例患者在重建时已出现淋巴水肿。所有淋巴SCIP皮瓣均完全存活。预防性转移淋巴皮瓣的4例患者中均未发生淋巴水肿(平均随访:37.5个月)。在重建时已出现淋巴水肿的3例患者中,最后一次随访(平均:29.0个月)时估计体积减少的平均率为12.6%。在DIEP皮瓣乳房重建中从4区获取的淋巴SCIP皮瓣可在不增加供区的情况下有助于改善或预防淋巴水肿。